Gossamer Bio, Inc. (GOSS)
3.60
-0.02
(-0.55%)
USD |
NASDAQ |
Dec 12, 16:00
3.64
+0.04
(+1.11%)
After-Hours: 20:00
Gossamer Bio EPS Diluted (Quarterly): -0.2115 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| XOMA Royalty Corp. | 0.6991 |
| Rezolute, Inc. | -0.1755 |
| PepGen Inc. | -0.5246 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -48.22M |
| Revenue (Quarterly) | 13.29M |
| Total Expenses (Quarterly) | 61.52M |
| Enterprise Value | 855.89M |
| Gross Profit Margin (Quarterly) | 98.35% |
| Profit Margin (Quarterly) | -362.7% |
| Earnings Yield | -19.09% |
| Normalized Earnings Yield | -18.45 |